Search - tctmd.com

Displaying 121 - 140 of 306

Sort: Relevancy | Date

Presentation TCT 2019

PCI vs. CABG in Multivessel Disease (With and Without Diabetes): Latest Clinical Trial Data

Presenter: Sripal Bangalore

September 27, 2019

Presentation TCT 2019

The Role of Antiplatelet Agents in Patients With Diabetes and Coronary Disease

Presenter: Marc Bonaca

September 26, 2019

Presentation ESC 2019

THEMIS: Ticagrelor Added to Aspirin in Patients with Stable Coronary Disease and Diabetes

Presenter: Deepak Bhatt

September 01, 2019

Presentation TVT 2019

Diabetes Mellitus: Is There a True Paradoxical Clinical Outcome After AVR?

Presenter: Rashad Belin

June 13, 2019

Presentation ISET 2019

Case-Based Tibial Arterial Disease

Presenter: Alex Powell

January 30, 2019

Presentation

SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization in FREEDOM

December 10, 2018

Presentation CDM 2018

Beyond Limb Salvage: Life Salvage

Presenter: Alan J. Block

October 12, 2018

Presentation TCT Abstracts Posters 2018

Impact of HDL to major adverse limb event in end-stage renal disease on hemodialysis due to diabetic nephropathy. from PREDICT study

Presenter: Tamon Kato

September 25, 2018

Presentation TCT Abstracts Posters 2018

Impact of Diabetes Mellitus on Vascular Healing Process after Everolimus-Eluting Stent Implantation: an Optical Coherence Tomography study

Presenter: Hirofumi Hioki

September 25, 2018

Presentation TCT Abstracts Posters 2018

Contemporary Evolutionary Analysis of Percutaneous Coronary Intervention in Diabetics

Presenter: Frederico Lopes de Oliveria

September 25, 2018

Presentation TCT 2018

CHIP in The Diabetic Patient: Special Considerations

Presenter: David J. Maron, Steven P. Marso, Cindy L. Grines

September 22, 2018

Presentation TCT 2018

Complete Revascularization is the Missing Link to Improve Diabetic PCI Outcomes

Presenter: David J. Maron, Steven P. Marso, Konstantinos Dean Boudoulas

September 22, 2018

Presentation TCT 2018

When is PCI a Valid Alternative To Only Medical Therapy or CABG in the Diabetic Patient?

Presenter: David J. Maron, Steven P. Marso, Sripal Bangalore

September 22, 2018

Presentation TCT 2018

Medical Therapy for Whom and When: What is the Ceiling of Medical Therapy?

Presenter: David J. Maron, Steven P. Marso, Norman E. Lepor

September 22, 2018

Presentation TCT 2018

Comprehensive CV Risk Reduction Strategy in Diabetics

Presenter: David J. Maron, Steven P. Marso, Kurt Huber

September 22, 2018

Presentation TCT 2018

Mortality and Stroke Outcomes of PCI vs CABG in MVD and LMD With and Without Diabetes

Presenter: Antonio Colombo, Jeffrey W. Moses, Stuart J. Head

September 22, 2018

Presentation TCT 2018

State-of-the-Art: Medical Therapies for CHF (With a Focus on Diabetes)

Presenter: James E. Udelson, Clyde W. Yancy, Ileana L. Pina

September 22, 2018

Presentation ESC 2018

ASCEND Randomized placebo-controlled trial of aspirin

Presenter: Jane Armitage

August 27, 2018

ASCEND A randomized trial of omega-3 fatty acids (fish oil) versus placebo

Presentation ESC 2018

ASCEND A Randomized Trial of Omega-3 Fatty Acids (fish oil) vs Placebo

Presenter: Jane Armitage

August 27, 2018

Presentation ACC 2018

CANTOS: Anti-Inflammatory Therapy with Canakinumab for the Prevention and Management of Diabetes

Presenter: Brendan M. Everett

March 12, 2018

Advertisement

PCI vs. CABG in Multivessel Disease (With and Without Diabetes): Latest Clinical Trial Data

The Role of Antiplatelet Agents in Patients With Diabetes and Coronary Disease

THEMIS: Ticagrelor Added to Aspirin in Patients with Stable Coronary Disease and Diabetes

Diabetes Mellitus: Is There a True Paradoxical Clinical Outcome After AVR?

Case-Based Tibial Arterial Disease

SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization in FREEDOM

Beyond Limb Salvage: Life Salvage

Impact of HDL to major adverse limb event in end-stage renal disease on hemodialysis due to diabetic nephropathy. from PREDICT study

Impact of Diabetes Mellitus on Vascular Healing Process after Everolimus-Eluting Stent Implantation: an Optical Coherence Tomography study

Contemporary Evolutionary Analysis of Percutaneous Coronary Intervention in Diabetics

CHIP in The Diabetic Patient: Special Considerations

Complete Revascularization is the Missing Link to Improve Diabetic PCI Outcomes

When is PCI a Valid Alternative To Only Medical Therapy or CABG in the Diabetic Patient?

Medical Therapy for Whom and When: What is the Ceiling of Medical Therapy?

Comprehensive CV Risk Reduction Strategy in Diabetics

Mortality and Stroke Outcomes of PCI vs CABG in MVD and LMD With and Without Diabetes

State-of-the-Art: Medical Therapies for CHF (With a Focus on Diabetes)

ASCEND Randomized placebo-controlled trial of aspirin

ASCEND A Randomized Trial of Omega-3 Fatty Acids (fish oil) vs Placebo

CANTOS: Anti-Inflammatory Therapy with Canakinumab for the Prevention and Management of Diabetes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content